Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trialBruno François, Richard S. Hotchkiss, Robin Jeannet et al.|JCI Insight|2018Cited by 412
IL-7 Engages Multiple Mechanisms to Overcome Chronic Viral Infection and Limit Organ PathologyMarc Pellegrini, Tak W. Mak, Brigitte Assouline et al.|Cell|2011Cited by 304
Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapiesMarc Pellegrini, Tak W. Mak, Thomas Calzascia et al.|Nature Medicine|2009Cited by 226
Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trialThomas Daix, Bruno François, Armelle Mathonnet et al.|Annals of Intensive Care|2023Cited by 76
A randomized, double-blind, placebo-controlled trial of IL-7 in critically ill patients with COVID-19Manu Shankar‐Hari, Richard S. Hotchkiss, Bruno François et al.|JCI Insight|2025Cited by 21